Loading...

Our Team

>Our Team
Our Team2018-10-09T12:42:09+00:00

Thomas Fairfull

President, Founder, CEO and Director

Thomas Fairfull serves as President, Chief Executive Officer and Director of FSD Pharma Inc. Mr. Fairfull has extensive experience in guiding companies through the process of developing, testing and commercializing products and consulting with companies bringing innovative products to market. In 2001, Mr. Fairfull founded a company specializing in on- board hydrogen generation technology, which is being used by PepsiCo.

In 2004, he successfully raised in excess of $20 million in private equity and became President and Chief Executive Officer of a TSX Venture Exchange-traded corporation.

Zeeshan Saeed

Executive Vice President, Co-founder and Director

Mr. Saeed is an entrepreneur and is one of the founding members of FV Pharma inc which is now wholly owned by FSD Pharma Inc. He has been involved with the company from the beginning since July of 2013. Mr. Saeed provided consulting advice to FV Pharma and was instrumental for raising the initial seed capital. He played a key role in bringing together a team of professionals in the development of the Corporation business plan as well as bringing key relationships to the company. He has experience in international capital markets and has helped various startups with the process of raising initial funding and getting listed on various stock exchanges.

Mr. Saeed is an Engineer by qualification and is currently the Executive Vice President and Director of FSD Pharma inc. Before entering capital markets Mr. Saeed was the founder and CEO of Platinum telecommunications inc. Mr. Saeed grew the company to a stage at which it was taken over by a public company.

Anthony Durkacz

Director

Anthony Durkacz is currently a Director and Executive Vice President at First Republic Capital Corp. since January 2014. First Republic Capital Corp. has acted as the exclusive agent of the Company and has raised approximately $53,000,000.00of equity capital to date. Previously he was President of Capital Ideas Investor Relations from January to December 2013. Before that he was a Director and CFO of Snipp Interactive Inc. (TSXV: SPN) from January 2011 to January 2013. He was instrumental in the financing and public listing of the mobile marketing company with operations in Canada, the USA, Mexico and India.

Mr. Durkacz is also the owner and President of Fortius Research & Trading Corp., which provides financial and investor relations consulting services to micro and small cap companies in various sectors, and develops investment strategies for high net worth individuals. From 2006 to 2009, he served as COO and CFO of MKU Canada Inc. engaging in mergers and acquisitions globally, and from 2002 to 2006 he served as the CFO of Astris Energi Inc., a dually listed public company in the USA and Canada which was acquired by an international conglomerate. He began his career at TD Securities on the capital markets trading floor. Mr. Durkacz holds an Honours Bachelor of Business Administration from Brock University with a major in both Accounting and Finance.

Michael Ash

Chief Commercial Officer

Michael Ash is currently Chief Commercial Officer of FV Pharma Inc. He brings a wealth of pharmaceutical industry expertise to FV Pharma in the areas of domestic and international sales and distribution, and product and brand development. Michael has an extensive network of retail relationships that he will leverage to develop and grow FV Pharma’s distribution network across Canada, thereby enabling the sale and supply of medical pharmaceutical-grade cannabis on a national basis.

Michael has held various high profile positions in the pharmaceutical industry. From 2015 to 2018, Michael was President of Pharmetics Inc. and was identified by the private equity firm that owned the company as the ideal industry expert capable of rebuilding the business, increasing sales and selling the company in 2018. From 2013 to 2015, Michael was President of NutraLab Canada Ltd. (“NutraLab) where he developed and launched private label brands of vitamins, minerals and supplements for large retailers across the country. From 1997 to 2013, Michael held the role of Senior Vice-President of Sales and Marketing at Pharmetics Inc. where he successfully grew sales of vitamins and over the counter (OTC) products from 15 million to close to 100 million dollars. He was able to accomplish substantial sales growth due to his strong retail relationships allowing the business to become the number one supplier of private label OTC products in Canada. From 1984 to 1995, Michael held progressive sales roles at Apotex Inc., including the role of Managing Director International where he was accountable for developing international distribution networks for the company’s generic drug brands. In his role, Michael travelled extensively around the world to establish joint ventures and distribution channels on behalf of the company. During his tenure, international sales grew to over 50 million dollars. Michael holds a BA in Political Science from McGill University.

Donal V. Carroll, CPA

Chief Financial Officer and Director

Donal Carroll is currently the Chief Financial Officer of FSD Pharma Inc. Mr. Carroll has 15 years of corporate finance leadership and public company experience, as well as deep expertise in syndicate investing both in equity and debt securities. With a balance of prudent financing practices and unique insights, Mr. Carroll has successfully guided companies for expansion and growth. Throughout his tenure with Danaher (DHR:NYSE), Alberto Culver (ACV:NYSE) – now Unilever (UL:NYSE) and Cardinal Meats, Mr. Carroll was instrumental in major restructuring activities, mergers and acquisitions, and the implementations of new internal controls and ERP systems resulting in significant efficiencies through periods of substantial change and strong company growth.

Mr. Carroll currently sits on the Board of Directors for FV Pharma and Bird River Resources (BDR-CSE) where he has led significant investor relations and merger activity. He holds a CPA-CMA designation as well as a Bachelor of Commerce degree from University College Dublin (UCD).

Gerald Goldberg, CPA, CA

Director

Gerald Goldberg, CPA, CA, served as Interim Chief Executive Officer of Canada House Wellness Group Inc. from April 15, 2016 to December 22, 2017. Mr. Goldberg has been the President at Leo Acquisitions Corp., since October 2009 and serves as its Chief Executive Officer. He serves as the President of SLF Capital Markets Inc. He serves as a Senior Partner in the accounting firm of Schwartz Levitsky Feldman LLP and serves as its Head of the audit division. Mr. Goldberg served as Chief Executive Officer, President and Chief Financial Officer of Victory Capital Corp. until March 7, 2017. Mr. Goldberg served as the Chief Executive Officer, President of Prime City One Capital Corp. until July 18, 2016. He has been with Schwartz Levitsky Feldman LLP since 1992.

Mr. Goldberg has over 30 years of experience in the service, distribution, retail, mining, natural resources and oil & gas, real estate, not-for-profit entities and manufacturing industries, with a strong emphasis in taxation and business advisory services. He served as a Partner in the Predecessor firm of Grant Thornton for over 15 years. He headed the U.S. Public Company audit division of Academy Capital Corp. Mr. Goldberg has been a Director of Gravitas Financial Inc. since May 12, 2016 and Gilla Inc. since June 29, 2016. He has been an Independent Director at Capricorn Business Acquisitions Inc. since May 7, 2008. He has been a Director of Baymount Incorp. since April 2004. He has been Director at Blue Nordic Partners Inc. since June 01, 2016. He has been a Director at Leo Acquisitions Corp. since October 28, 2009 and InterAmerican Gaming, Inc since January 17, 2012. He serves as a Director of Grasslands Entertainment Inc. He served as a Director of Pinetree Capital Ltd., from 2010 to April 29, 2016. He served as Director of Prime City One Capital Corp. since July 2015 until July 18, 2016. Mr. Goldberg served as a Non-Executive Director of Emerge Resources Corp. (formerly Beatrix Ventures Inc) from August 29, 2013 to May 26, 2015. He served as a Director of Victory Capital Corp. until March 7, 2017. He served as a Director of Lakeside Minerals Inc., since December 2008. He served as a Director of Keyuan Petrochemicals, Inc. from July 1, 2010 to June 29, 2012. He served as a Director of Ever-Glory.

Vladimir Klacar

Director

Vladimir Klacar is Associate General Counsel & Head of Regulatory Affairs at Auxly Cannabis Group Inc. Vladimir is widely regarded as one of Canada’s leading advisors in the Canadian cannabis industry.

Prior to joining Auxly, Vladimir was an associate in the Cannabis Group at Bennett Jones LLP. In this role, he had a broad corporate commercial practice where he advised local and international clients on regulatory matters such as licensing and compliance pursuant to the Access to Cannabis for Medical Purposes Regulations and the Narcotic Control Regulations. Vladimir has represented a variety of cannabis industry participants on complex regulatory matters including licensed producers, licensed producer applicants, licensed dealers, e-commerce platforms, seed-to-sale software developers, design and build firms, patient aggregators, equipment manufacturers and distributors, and cannabis branding companies.

Vladimir earned dual law (J.D./J.D.) degrees from the University of Windsor and University of Detroit Mercy.

Dr. Zohar Koren

Head of Scientific Advisory Board

Dr. Zohar Koren, Ph.D, MBA Co-founded Cannabics Inc., in 2012 and serves as its Chief Executive Officer and Director. Dr. Koren served as the Chief Executive Officer of Cannabics Pharmaceuticals Inc. (formerly, American Mining Corporation) from April 29, 2014 to January 2015. Dr. Koren served as Director of Business Development of Aposense, a publicly traded pharmaceutical development company. Prior to that, he served as Business Development Manager at Harel-Hertz, where he led the Life Sciences Department of Business Development in Japan.

Dr. Koren has also provided strategic consulting services for several leading Israeli venture capital firms specific to the pharmaceutical and medical device arena. Dr. Koren served as a Director of Cannabics Pharmaceuticals Inc. from April 29, 2014 to January 2015. Dr. Koren holds a Ph.D. in Computational Biology and an M.Sc. in Evolutionary and Environmental Sciences, both Magna Cum Laude, from the University of Haifa and a B.Sc. in Mathematics, Physics and Biology from the Hebrew University in Jerusalem.

John Tokarsky

Mr. Tokarsky is currently the Corporate Secretary and Controller of the company and provides these services through Tokarsky Corporate Services Limited, a company which has been associated with Mr. Tokarsky since 1984. Tokarsky Corporate Services Limited has provided accounting, bookkeeping and corporate secretarial services to junior reporting issuers in Canada since 1971, most of them being involved in the exploration of minerals, oil and gas and industrial companies in various sectors. Mr. Tokarsky is a college graduate, has accounting training and holds CSC and CPH certifications from the Canadian Securities Institute.

Mr. Tokarsky has more than 34 years of experience in the industry having assisted approximately 100 junior public companies with their corporate secretarial requirements, accounting issues, public listing issues, securities act and continuous disclosure obligations. He has a strong practical and current working knowledge of securities and corporate laws, regulations, practices and policies. He upholds regulatory and compliance best practices and has a proven track record in dealing with stock exchanges, securities commissions and other regulatory bodies.

Mr. Tokarsky has acted as a director and/or senior officer of a number of his clients as need be. Most notably he is currently the Chief Financial Officer of Bird River Resources Inc. since October 2017. He also acted as Controller, Corporate Secretary and Treasurer of Augustine Ventures Inc. from November 2010 to October 2014 including acting as its Chief Financial Officer for a period during that time.

Sandy Huard

Head of Investor Relations

Sandy is a professional marketing and communications executive, senior strategist and consultant with over 21 years of marketing and sales experience leading national marketing teams, driving sales performance and launching national brands in the financial services industry. Throughout her career, Sandy has worked with banks, technology companies, wireless carriers, and agencies as a marketing & communications consultant, senior strategist and executive sales and leadership coach.

Prior to joining FSD Pharma, Sandy was Head of Marketing & Communications for FNF Canada, the Canadian subsidiary of the largest title insurer in North America. In the five years prior, she was Senior Sales Advisor to executives and sales leaders at BMO Financial Group and was responsible for building sales capabilities and driving sales results in the branch network, the national customer contact center and across the national specialized sales teams. Previous to that, Sandy was Director of Marketing & Communications at Alterna Savings and Director and Head of Marketing & Communications at Computershare Trust Company of Canada. In her career at BMO, Sandy held numerous roles, including Senior Program Manager, Senior Product Manager and Strategic Marketing Manager. She began her 25 year career as a Treasury Analyst and Cash Manager with Confederation Life Insurance Company.

Sandy holds an MBA in Finance and Marketing from the Schulich School of Business, a Bachelor of Science Education from Brandon University and an Honors Bachelor of Science from McMaster University. She is a CTA Certified Sales Coach, a Certified Positive Psychology Coach and a Certified DiSC practitioner. Sandy is a published author and is fluent in French.